118 related articles for article (PubMed ID: 20616591)
21. Thermal ablation therapy for hepatocellular carcinoma: comparison between radiofrequency ablation and percutaneous microwave coagulation therapy.
Ohmoto K; Yoshioka N; Tomiyama Y; Shibata N; Kawase T; Yoshida K; Kuboki M; Yamamoto S
Hepatogastroenterology; 2006; 53(71):651-4. PubMed ID: 17086861
[TBL] [Abstract][Full Text] [Related]
22. Recurrence incidence of small HCC in cirrhosis patients by ablation versus injection.
Wakui N; Iida K; Ikehara T; Takayama R; Shiozawa K; Takahashi M; Nagai H; Watanabe M; Ishii K; Igarashi Y; Sumino Y
Hepatogastroenterology; 2010; 57(98):195-201. PubMed ID: 20583411
[TBL] [Abstract][Full Text] [Related]
23. Percutaneous radiofrequency ablation for hepatocellular carcinoma. An analysis of 1000 cases.
Tateishi R; Shiina S; Teratani T; Obi S; Sato S; Koike Y; Fujishima T; Yoshida H; Kawabe T; Omata M
Cancer; 2005 Mar; 103(6):1201-9. PubMed ID: 15690326
[TBL] [Abstract][Full Text] [Related]
24. Percutaneous thermal ablation of medium and large hepatocellular carcinoma: long-term outcome and prognostic factors.
Yin XY; Xie XY; Lu MD; Xu HX; Xu ZF; Kuang M; Liu GJ; Liang JY; Lau WY
Cancer; 2009 May; 115(9):1914-23. PubMed ID: 19241423
[TBL] [Abstract][Full Text] [Related]
25. Percutaneous radiofrequency ablation with cooled electrodes combined with hepatic arterial balloon occlusion in hepatocellular carcinoma.
Yamasaki T; Kimura T; Kurokawa F; Aoyama K; Ishikawa T; Tajima K; Yokoyama Y; Takami T; Omori K; Kawaguchi K; Tsuchiya M; Terai S; Sakaida I; Okita K
J Gastroenterol; 2005 Feb; 40(2):171-8. PubMed ID: 15770401
[TBL] [Abstract][Full Text] [Related]
26. Time-lag performance of radiofrequency ablation after percutaneous ethanol injection for the treatment of hepatocellular carcinoma.
Kurokohchi K; Masaki T; Watanabe S; Nakai S; Deguchi A; Morishita A; Yoneyama H; Ohgi T; Ono M; Yoshitake A; Kako T; Ohmachi N; Kiuchi T; Maeta T; Yoshida M; Mori Y; Kohi F; Kuriyama S
Int J Oncol; 2006 Apr; 28(4):971-6. PubMed ID: 16525648
[TBL] [Abstract][Full Text] [Related]
27. Percutaneous ablation of hepatocellular carcinoma: state-of-the-art.
Lencioni R; Cioni D; Crocetti L; Bartolozzi C
Liver Transpl; 2004 Feb; 10(2 Suppl 1):S91-7. PubMed ID: 14762847
[TBL] [Abstract][Full Text] [Related]
28. [A tailored approach to radiofrequency ablation of hepatocellular carcinoma and its outcome].
Chen MH; Yang W; Yan K; Wu JY; Dai Y; Gao W; Zhang H; Wu W
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2008 Feb; 30(1):15-21. PubMed ID: 18361046
[TBL] [Abstract][Full Text] [Related]
29. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.
Lam VW; Ng KK; Chok KS; Cheung TT; Yuen J; Tung H; Tso WK; Fan ST; Poon RT
J Am Coll Surg; 2008 Jul; 207(1):20-9. PubMed ID: 18589357
[TBL] [Abstract][Full Text] [Related]
30. Prospective study of a 'popping' sound during percutaneous radiofrequency ablation for hepatocellular carcinoma.
Fernandes ML; Lin CC; Lin CJ; Chen WT; Lin SM
J Vasc Interv Radiol; 2010 Feb; 21(2):237-44. PubMed ID: 20031448
[TBL] [Abstract][Full Text] [Related]
31. Radiofrequency ablation with hand-assisted laparoscopic surgery for the treatment of hepatocellular carcinoma in the caudate lobe.
Ishiko T; Beppu T; Sugiyama S; Masuda T; Takahashi M; Komori H; Takamori H; Hirota M; Kanemitu K; Baba H
Surg Laparosc Endosc Percutan Tech; 2008 Jun; 18(3):272-6. PubMed ID: 18574414
[TBL] [Abstract][Full Text] [Related]
32. Radiofrequency ablation combined with percutaneous ethanol injection in the treatment of hepatocellular carcinoma and portal vein neoplastic thrombosis.
Poggi G; Gatti C; Teragni C; Delmonte A; Bernardo G
Anticancer Res; 2004; 24(4):2419-21. PubMed ID: 15330193
[TBL] [Abstract][Full Text] [Related]
33. [Evaluation of combined percutaneous radio-frequency ablation and percutaneous ethanol injection after transcatheter arterial chemoembolization for hepatocellular carcinoma].
Zhang FJ; Wu PH; Zhao M; Gu YK; Zhang L; Tan ZB
Zhonghua Zhong Liu Za Zhi; 2005 Apr; 27(4):248-50. PubMed ID: 15949431
[TBL] [Abstract][Full Text] [Related]
34. [The comparative results of radiofrequency ablation versus surgical resection for the treatment of hepatocellular carcinoma].
Cho CM; Tak WY; Kweon YO; Kim SK; Choi YH; Hwang YJ; Kim YI
Korean J Hepatol; 2005 Mar; 11(1):59-71. PubMed ID: 15788886
[TBL] [Abstract][Full Text] [Related]
35. [Standard treatment of liver malignancies with radiofrequency ablation].
Chen MH; Yang W; Yan K; Gao W; Dai Y; Wang YB; Huo L; Zhang H; Huang XF
Zhonghua Yi Xue Za Zhi; 2005 Jul; 85(25):1741-6. PubMed ID: 16253159
[TBL] [Abstract][Full Text] [Related]
36. Seeding following percutaneous diagnostic and therapeutic approaches for hepatocellular carcinoma. What is the risk and the outcome? Seeding risk for percutaneous approach of HCC.
Stigliano R; Marelli L; Yu D; Davies N; Patch D; Burroughs AK
Cancer Treat Rev; 2007 Aug; 33(5):437-47. PubMed ID: 17512669
[TBL] [Abstract][Full Text] [Related]
37. Comparison of percutaneous and surgical approaches for radiofrequency ablation of small and medium hepatocellular carcinoma.
Khan MR; Poon RT; Ng KK; Chan AC; Yuen J; Tung H; Tsang J; Fan ST
Arch Surg; 2007 Dec; 142(12):1136-43; discussion 1143. PubMed ID: 18086979
[TBL] [Abstract][Full Text] [Related]
38. Obesity did not diminish the efficacy of percutaneous ablation for hepatocellular carcinoma.
Ohki T; Tateishi R; Shiina S; Sato T; Masuzaki R; Yoshida H; Kanai F; Obi S; Yoshida H; Omata M
Liver Int; 2007 Apr; 27(3):360-7. PubMed ID: 17355458
[TBL] [Abstract][Full Text] [Related]
39. Efficacy of radiofrequency ablation therapy compared to surgical resection in 164 patients in Japan with single hepatocellular carcinoma smaller than 3 cm, along with report of complications.
Hiraoka A; Horiike N; Yamashita Y; Koizumi Y; Doi K; Yamamoto Y; Hasebe A; Ichikawa S; Yano M; Miyamoto Y; Ninomiya T; Otomi Y; Kokame M; Iwamura T; Ishimaru Y; Sogabe I; Kashihara K; Nishiura S; Ootani H; Takamura K; Kawasaki H
Hepatogastroenterology; 2008; 55(88):2171-4. PubMed ID: 19260499
[TBL] [Abstract][Full Text] [Related]
40. Benefits of artificially induced pleural effusion and/or ascites for percutaneous radiofrequency ablation of hepatocellular carcinoma located on the liver surface and in the hepatic dome.
Iwai S; Sakaguchi H; Fujii H; Kobayashi S; Morikawa H; Enomoto M; Tamori A; Kawada N
Hepatogastroenterology; 2012; 59(114):546-50. PubMed ID: 22353522
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
